)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Trinity Biotech
Trinity Biotech (TRIB) investor relations material
Trinity Biotech Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary30 Apr, 2026
Executive summary
Like-for-like revenue for Q4 2025 was $11.0m, down from $15.1m in Q4 2024, mainly due to lower HIV sales and supply chain adjustments for TrinScreen demand.
Net loss for Q4 2025 was $17.5m (Q4 2024: $17.0m), impacted by a one-off $10.0m IFRS charge related to financing modifications.
For FY2025, like-for-like revenue was $43.3m, down from $58.8m in 2024, with net loss at $37.4m (2024: $31.8m).
Adjusted EBITDA improved to negative $0.5m in Q4 2025 (Q4 2024: negative $7.0m) and negative $5.9m for FY2025 (2024: negative $11.3m), reflecting transformation-driven profitability improvements.
Financial highlights
Q4 2025 total revenue: $11.1m (Q4 2024: $15.9m); FY2025 total revenue: $43.8m (2024: $61.6m).
Q4 2025 gross margin: 35.2% (Q4 2024: 30.8%); FY2025 gross margin: 38.6% (2024: 34.8%).
Q4 2025 gross profit: $3.9m (Q4 2024: $4.9m); FY2025 gross profit: $16.9m (2024: $21.4m).
Basic and diluted loss per ADS for Q4 2025: $0.9 (Q4 2024: $1.3); FY2025: $2.0 (2024: $1.8).
Outlook and guidance
Revenue and profitability improvements are expected as transformation initiatives continue and manufacturing transitions stabilize.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Trinity Biotech
- Up to $25M in equity financing via ADS offering supports diagnostics growth amid high leverage and Nasdaq risks.TRIB
Registration filing5 Mar 2026 - Q2 revenue up 14%, Point-of-Care sales surged 119%, and CGM development advanced toward pivotal trials.TRIBQ2 20241 Feb 2026
- Q3 revenue up 3%, Point-of-Care up 60%, and profitability initiatives progressing.TRIBQ3 202413 Jan 2026
- Revenue and margins declined in Q1 2025, but a strong rebound is expected in Q2.TRIBQ1 202523 Dec 2025
- Revenue declined and losses narrowed in Q2 2025 amid restructuring and funding uncertainty.TRIBQ2 202523 Dec 2025
- Gross margin rose to 45.2% and Adjusted EBITDA turned positive despite a $5.1m net loss.TRIBQ3 202523 Dec 2025
- Registering up to $50M in securities to fund growth amid Nasdaq compliance risks.TRIBRegistration Filing16 Dec 2025
- Registers 650,000 ADSs for resale amid strategic expansion and ongoing Nasdaq compliance risks.TRIBRegistration Filing16 Dec 2025
- Shelf registration allows flexible offerings; advisor compensated in cash or ADSs with resale controls.TRIBRegistration Filing16 Dec 2025
Next Trinity Biotech earnings date
Q1 202622 May, 2026
Trinity Biotech
Next Trinity Biotech earnings date
Q1 202622 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage